|
|
 |
I've been cut off neomycin beclomethasone clotrimazole & lignocaine Mead Johnson said the payment, which resolves the NDRCreview, would reduce its full-year earnings by about 12 centsper share, but it reiterated its 2013 earnings forecast forprofit, excluding one-time items, of $3.22 to $3.30 per share.
2021-2-2 9:27:14 |
|
|
|
